Original document(42 pages)  中文版
    The invention relates to a compound having general formula (I), wherein: m represents an integer equal to 1 or 2; R1 represents an aryl- or heteroaryl-type group that is optionally substituted by one or more R3 or R4 groups; R2 represents a group having general formula CHR5CONHR6; R3 represents a halogen atom or a hydroxy, cyano, nitro, C1-6-alkyl, C1-6-alkoxy, C1-6-thioalkyl, C1-6-fluoroalkyl, C1-6-fluoroalkoxy, -O-(C2-3-alkylene)-, -O-(C1-3-alkylene)-O-, C1-6-fluorothioalkyl, C3-7-cycloalkyl, C3-7-cycloalkyl-C1-3-alkylene, piperidinyl, benzyloxy, piperazinyl, pyrrolidinyl, morpholinyl, phenyloxy, NR7R8, NHCOR7, NHSO2R7, COR7, C02R7, CONR7R8, SO2R7 or SO2NR7R8 group; R4 represents an aryl- or heteroaryl-type group, whereby the R4 group(s) can be substituted by one or more identical or different R3 groups; R5 represents a hydrogen atom or a C1-3-alkyl group; R6 represents a hydrogen atom or a C1-6-alkyl, C3-7-cycloalkyl or C3-7-cycloalkyl-C1-3-alkylene group; and R7 and R8 represent, independently of each other, a hydrogen atom, a C1-3-alkyl group or a phenyl group, said compound taking the form of a base, an acid addition salt, a hydrate or a solvate. The invention also relates to the use of the compound in therapeutics.
Application Number
申请号
200480040912 Application Date
申请日
2004.12.17
Title 名称 Derivatives of 1-piperazine- and 1-homopiperazine-carboxylates, preparation method thereof and use of same in therapeutics
Publication Number
公开号
1922161 Publication Date
公开日
2007.02.28
Approval Pub. Date Granted Pub. Date
International Classification 分类号 C07D295/185;C07D311/04;C07D317/58;C07D307/81;C07D495/04;A61K31/495;A61K31/496;A61K31/55;C07C235/06;A61P29/00;A61P25/00;A61P35/00;A61P37/00;A61P31/00;A61P33/00
Applicant(s) Name
申请人
Sanofi Aventis
Address 地址
Inventor(s) Name 发明人 Abouabdellah Ahmed;Almario Garcia Antonio;Hoornaert Christian;Li Adrien Tak
Attorney & Agent 代理人 liu weisheng lin sen
More information 更  多  信  息


 Related patents information
Google
Note:All patent data come from State Intellectual Property Office of the People's Republic of China. If there were discrepancies between here and the State Intellectual Property office, the later is more accurate. The patent data is only for public exchange and learning purposes. We are not responsible for the adverse consequences with unverified use of the data.